Lactobacillus reuteri DSM 17938 for the prevention of nosocomial diarrhoea possibly caused by rotavirus infection

Trial Profile

Lactobacillus reuteri DSM 17938 for the prevention of nosocomial diarrhoea possibly caused by rotavirus infection

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2012

At a glance

  • Drugs Lactobacillus reuteri (Primary)
  • Indications Diarrhoea; Nosocomial infections; Rotavirus infections
  • Focus Therapeutic Use
  • Acronyms PND
  • Most Recent Events

    • 14 Feb 2012 New trial record
    • 03 Feb 2012 Results published in the Journal of Pediatrics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top